BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 29562089)

  • 21. [Fabry disease--a provocation for pediatrics].
    Hoffmann B; Mayatepek E
    Klin Padiatr; 2006; 218(1):38-40. PubMed ID: 16432775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac Involvement in Fabry Disease and the Role of Multimodality Imaging in Diagnosis and Disease Monitoring.
    Umer M; Motwani M; Jefferies JL; Nagueh SF; Kalra DK
    Curr Probl Cardiol; 2023 Jan; 48(1):101439. PubMed ID: 36202174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pseudoacromegalic facial features in Fabry disease.
    Hogarth V; Hughes D; Orteu CH
    Clin Exp Dermatol; 2013 Mar; 38(2):137-9. PubMed ID: 22731890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fabry disease-often seen, rarely diagnosed.
    Hoffmann B; Mayatepek E
    Dtsch Arztebl Int; 2009 Jun; 106(26):440-7. PubMed ID: 19623315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurological manifestations in Fabry's disease.
    Møller AT; Jensen TS
    Nat Clin Pract Neurol; 2007 Feb; 3(2):95-106. PubMed ID: 17279083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enzyme replacement therapy in two Japanese siblings with Fabry disease, and its effectiveness on angiokeratoma and neuropathic pain.
    Furujo M; Kubo T; Kobayashi M; Ohashi T
    Mol Genet Metab; 2013 Nov; 110(3):405-10. PubMed ID: 23906479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cornea Verticillata in classical Fabry disease, first from Sri Lanka: a case report.
    Hewavitharana H; Jasinge E; Abeysekera H; Wanigasinghe J
    BMC Pediatr; 2020 Jul; 20(1):338. PubMed ID: 32641113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pediatric Fabry disease.
    Ries M; Gupta S; Moore DF; Sachdev V; Quirk JM; Murray GJ; Rosing DR; Robinson C; Schaefer E; Gal A; Dambrosia JM; Garman SC; Brady RO; Schiffmann R
    Pediatrics; 2005 Mar; 115(3):e344-55. PubMed ID: 15713906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. When and How to Diagnose Fabry Disease in Clinical Pratice.
    Michaud M; Mauhin W; Belmatoug N; Garnotel R; Bedreddine N; Catros F; Ancellin S; Lidove O; Gaches F
    Am J Med Sci; 2020 Dec; 360(6):641-649. PubMed ID: 32723516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A diagnosis of Fabry gastrointestinal disease by chance: a case report.
    Feriozzi S; Torre ES; Ranalli TV; Cardello P; Morrone A; Ancarani E
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):163-5. PubMed ID: 17273003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fabry disease. A case report.
    Kotnik J; Kotnik F; Desnick RJ
    Acta Dermatovenerol Alp Pannonica Adriat; 2005 Mar; 14(1):15-9. PubMed ID: 15818441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Enzyme replacement therapy in patients with Fabry disease: state of the art and review of the literature].
    Riccio E; Capuano I; Visciano B; Marchetiello C; Petrillo F; Pisani A
    G Ital Nefrol; 2013; 30(5):. PubMed ID: 24402625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of patients with Fabry disease in Argentina].
    AADELFA (Asociación Argentina de estudio de enfermedad de Fabry y otras enfermedades lisosomales)
    Medicina (B Aires); 2010; 70(1):37-43. PubMed ID: 20228022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents.
    Ries M; Ramaswami U; Parini R; Lindblad B; Whybra C; Willers I; Gal A; Beck M
    Eur J Pediatr; 2003 Nov; 162(11):767-72. PubMed ID: 14505049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Prevalence of Fabry Disease in Patients with Chronic Kidney Disease in Turkey: The TURKFAB Study.
    Turkmen K; Guclu A; Sahin G; Kocyigit I; Demirtas L; Erdur FM; Sengül E; Ozkan O; Emre H; Turgut F; Unal H; Karaman M; Acıkel C; Esen H; Balli E; Bıtırgen G; Tonbul HZ; Yılmaz MI; Ortiz A
    Kidney Blood Press Res; 2016; 41(6):1016-1024. PubMed ID: 28006774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Molecular pathology and clinical manifestations of Fabry disease].
    Rákóczi E; Görögh S; Grubits J; Erdos M; Garzuly F; Hahn K; Bencsik K; Vécsei L; Trinn C; Kristóf E; Mogyorósy G; Tóth B; Maródi L
    Orv Hetil; 2007 Jun; 148(23):1087-94. PubMed ID: 17545117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fabry disease - the profile of an orphan disease].
    Tamò R; Zweifel SA; Beuschlein F; Nowak A
    Ther Umsch; 2018 Nov; 75(4):217-224. PubMed ID: 30468120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey.
    Mehta A; Ricci R; Widmer U; Dehout F; Garcia de Lorenzo A; Kampmann C; Linhart A; Sunder-Plassmann G; Ries M; Beck M
    Eur J Clin Invest; 2004 Mar; 34(3):236-42. PubMed ID: 15025684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gaucher disease and Fabry disease: new markers and insights in pathophysiology for two distinct glycosphingolipidoses.
    Ferraz MJ; Kallemeijn WW; Mirzaian M; Herrera Moro D; Marques A; Wisse P; Boot RG; Willems LI; Overkleeft HS; Aerts JM
    Biochim Biophys Acta; 2014 May; 1841(5):811-25. PubMed ID: 24239767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neurological manifestations of Fabry disease].
    Mendióroz M; Fernández-Cadenas I; Montaner J
    Rev Neurol; 2006 Dec 16-31; 43(12):739-45. PubMed ID: 17160925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.